Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Johanna Distefano

TitleAffiliate - NJH
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-BioChem&Molecular Genetics

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Leti F, DiStefano JK. Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications. Genes (Basel). 2017 Aug 22; 8(8). PMID: 28829354.
      View in: PubMed
    2. Wood GC, Chu X, Argyropoulos G, Benotti P, Rolston D, Mirshahi T, Petrick A, Gabrielson J, Carey DJ, DiStefano JK, Still CD, Gerhard GS. A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. Sci Rep. 2017 Mar 07; 7:43238. PMID: 28266614.
      View in: PubMed
    3. DiStefano JK. miRNA profiling for the early detection and clinical monitoring of diabetic kidney disease. Biomark Med. 2017 Feb; 11(2):99-102. PMID: 28097875.
      View in: PubMed
    4. Hanson RL, Leti F, Tsinajinnie D, Kobes S, Puppala S, Curran JE, Almasy L, Lehman DM, Blangero J, Duggirala R, DiStefano JK. The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3. Mol Genet Metab. 2016 Jun; 118(2):128-37. PMID: 27117576; PMCID: PMC4880492 [Available on 06/01/17].
    5. DiStefano JK. Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes. Rev Diabet Stud. 2015 Fall-Winter; 12(3-4):260-76. PMID: 26859655.
      View in: PubMed
    6. DiStefano JK, Gerhard GS. Circulating microRNAs in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2016; 10(2):161-3. PMID: 26606259; PMCID: PMC4924611 [Available on 01/01/17].
    7. Gerhard GS, Still CD, DiStefano JK. High False-Negative Rate for Nonalcoholic Steatohepatitis in Extreme Obesity. Gastroenterology. 2016 Jan; 150(1):283-4. PMID: 26616574.
      View in: PubMed
    8. Leti F, Malenica I, Doshi M, Courtright A, Van Keuren-Jensen K, Legendre C, Still CD, Gerhard GS, DiStefano JK. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. Transl Res. 2015 Sep; 166(3):304-14. PMID: 26001595; PMCID: PMC4537840.
    9. Gerhard GS, DiStefano JK. Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol. 2015 Feb 27; 7(2):226-34. PMID: 25729477; PMCID: PMC4342604.
    10. Gerhard GS, Benotti P, Wood GC, Chu X, Argyropoulos G, Petrick A, Strodel WE, Gabrielsen JD, Ibele A, Still CD, Kingsley C, DiStefano J. Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity. J Obes. 2014; 2014:368210. PMID: 25610640; PMCID: PMC4290025.
    11. DiStefano JK, Kingsley C, Craig Wood G, Chu X, Argyropoulos G, Still CD, Doné SC, Legendre C, Tembe W, Gerhard GS. Genome-wide analysis of hepatic lipid content in extreme obesity. Acta Diabetol. 2015 Apr; 52(2):373-82. PMID: 25246029; PMCID: PMC4370808.
    12. DiStefano JK. Identification of novel genetic markers and improved treatment options for diabetic kidney disease. Biomark Med. 2010 Oct; 4(5):739-41. PMID: 20945986.
      View in: PubMed
    Distefano's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)